Thermogenesis Holdings

THMO · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About THMO

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.

Employees
25
Headquarters
Rancho Cordova, California
Listed
Jun 5, 1987
Sector
Health Care
Industry
Health Care Equipment & Supplies

THMO key statistics

Market cap
1.58K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
283
Volume
2.00K
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0001
52 Week low
$0.00

Thermogenesis Holdings (THMO) at a glance

As of Oct 20, 2026, Thermogenesis Holdings (THMO) shares are priced at $0.0001, giving the company a market cap of 1.58K and a price-to-earnings ratio of 0.00.

Volume so far is 2.00K shares, above the average of 283 shares a day.

Over the past year Thermogenesis Holdings has ranged from $0.00 to $0.0001, and now sits 100% of the way up that range.

Thermogenesis Holdings met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q1 FY24 it reported -$0.46 per share against an estimate of $0.0102.

THMO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 99.1% on average.

  1. Q4 FY21: reported -$9.90 per share against an estimate of -$2.75
  2. Q3 FY22: reported -$4.50 per share against an estimate of -$1.38
  3. Q4 FY22: reported -$3.83 per share against an estimate of -$0.918
  4. Q1 FY23: reported -$0.003 per share against an estimate of -$0.3162
  5. Q2 FY23: reported -$0.91 per share against an estimate of $0.0102
  6. Q3 FY23: reported -$1.44 per share against an estimate of -$0.2142
  7. Q4 FY23: reported -$1.47 per share against an estimate of -$0.0102
  8. Q1 FY24: reported -$0.46 per share against an estimate of $0.0102

Similar companies

Companies in the same industry as Thermogenesis Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.